Liver Biopsy Products Market to Reach USD 1.5 Billion by 2033 at a 6.2% CAGR - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - The rising prevalence of liver disease and advances in biopsy techniques are driving growth in liver biopsy products. According to Strategic Revenue Insights, the global liver biopsy products market is projected to reach USD 1.5 billion by 2033, registering a CAGR of 6.2% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

• Market value is projected to reach USD 1.5 billion by 2033, at a CAGR of 6.2% from 2025 to 2033.
• Hospitals remain the largest end-user segment.
• Demand for minimally invasive procedures is boosting needle and laparoscopic biopsies, and new techniques are improving diagnostic precision and patient comfort.
• North America holds the largest share, while Asia-Pacific is expected to grow fastest.
• Named market participants include Medtronic plc, Becton, Dickinson and Company, and Boston Scientific Corporation.

Report URL: https://www.strategicrevenueinsights.com/industry/liver-biopsy-products-market

Liver Disease Burden Drives Biopsy Product Demand

Growth is primarily driven by the increasing prevalence of liver diseases and advances in biopsy techniques that improve diagnostic precision.

Demand for minimally invasive procedures is boosting adoption of needle and laparoscopic biopsies. Collaborations between research institutes and healthcare providers are fostering innovation, and regulatory approvals and favorable reimbursement policies support expansion.

Market Segmentation

By Product Type: Needle, Transjugular, Laparoscopic, and Open Surgical Biopsy.

By End User: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, and Research Institutes. Hospitals are the largest.

By Procedure Type: Percutaneous, Transjugular, Laparoscopic, and Open Biopsy.

By Application: Cancer Diagnosis, Liver Cirrhosis, Hepatitis, and Fatty Liver Disease.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest market share, driven by high healthcare expenditure and advanced infrastructure, while Asia-Pacific is expected to witness the fastest growth due to rising healthcare awareness and improving facilities. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names Medtronic plc, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical, Argon Medical Devices, Inc., Merit Medical Systems, Inc., Hologic, Inc., INRAD, Inc., Veran Medical Technologies, Fujifilm Holdings Corporation, Cardinal Health, Inc., and Olympus Corporation as market participants.

Market Restraints

The high cost of biopsy procedures can limit access in low-income regions, and the risk of complications such as bleeding and infection can deter patients.

Related Reports

https://www.strategicrevenueinsights.com/industry/blood-bag-mixer-market

https://www.strategicrevenueinsights.com/industry/medical-grade-transportation-box-market

https://www.strategicrevenueinsights.com/industry/urine-sample-container-market

https://www.strategicrevenueinsights.com/industry/magnetic-hyperthermia-and-radiation-therapy-devices-market

https://www.strategicrevenueinsights.com/industry/caspase-assay-kits-market

https://www.strategicrevenueinsights.com/industry/pneumatic-pumps-for-lymphedema-market

https://www.strategicrevenueinsights.com/industry/real-time-pcr-qpcr-instruments-market

https://www.strategicrevenueinsights.com/industry/proton-therapy-machine-market

https://www.strategicrevenueinsights.com/industry/smart-electronic-stethoscopes-market

https://www.strategicrevenueinsights.com/industry/hospital-room-pressure-monitoring-system-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 1.5 billion by 2033.

What is the expected CAGR of the liver biopsy products market?

The market is projected to expand at a CAGR of 6.2% from 2025 to 2033.

Which segment is largest in the liver biopsy products market?

Hospitals remain the largest end-user segment.

Which region leads the liver biopsy products market?

North America holds the largest market share, driven by high healthcare expenditure and advanced infrastructure, while Asia-Pacific is expected to witness the fastest growth due to rising healthcare awareness and improving facilities.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases